跳至主要内容
临床试验/EUCTR2005-002466-11-GB
EUCTR2005-002466-11-GB进行中(未招募)不适用

A Pilot Study to Examine the Safety and Efficacy of Posterior Juxtascleral Triamcinolone acetonide administration, in addition to Visudyne photoynamic therapy for predominantly Classic Choroidal Neovascularisation secondary to age related Macular degeneration: an open label randomised active controlled trial. - Efficacy of Juxtascleral Triamcinolone acetonide as an adjunct to PDT

King's College Hospital0 个研究点目标入组 80 人开始时间: 2005年12月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients age 50 years or above with a clinical diagnosis of wet AMD,confirmed to be predominantly classic on fluorescein angiography.
  • Visual acuity must be 6/60 or better.
  • Able to give informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Medical conditions that are likely to interfere with scheduled study visits.
  • Other ophthalmic conditions that may interfere with the assessment of treatment.
  • High degree of short sightedness.
  • Previous photodynamic therapy or other treatment for CNV,such as argon laser.

研究者

相似试验

已完成
2 期
A Pilot Study to Evaluate the Safety and Efficacy of Rituximab in Combination with Out-Patient Based Vinorelbine, Gemcitabine and Pegfilgrastim (VGF)/Pegfilgrastim, Gemcitabine, Ifosfamide and Vinorelbine (F-GIV) Salvage Therapies in the treatment of Relapsed/Refractory CD20+ Lymphomas.Relapsed and refractory CD20+ lymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - High grade lymphomaCancer - Lymphoma (non Hodgkin's lymphoma) - Low grade lymphoma
ACTRN12606000386538Associate Professor Andrew Spencer12
进行中(未招募)
不适用
A pilot study to examine the efficacy and safety of escitalopram in doses up to 50 mg for the treatment of patients with Major Depressive Disorder (MDD). - Resistant Depression StudyMedDRA version: 9.1Level: LLTClassification code 10025453Term: Major depressive disorder NOSMajor Depressive Disorder
EUCTR2008-003359-58-GBCPS Research60
已完成
不适用
Combination therapy of Visudyne, Minocycline, Dexamethasone and Ranibizumab (VIMDER) for the treatment of subfoveal choroidal neovascularisation (CNV)Age-related macular degeneration
ISRCTN34410935King's College Hospital NHS Foundation Trust (UK)20
已完成
不适用
A pilot study to examine the safety and efficacy of posterior juxta-scleral (80 mg) triamcinolone acetonide, administration, in addition to Visudyne (verteporfin) photodynamic therapy for predominantly classic choroidal neovascularisation secondary to age-related macular degeneration: an open-label, randomised, active controlled trial
ISRCTN33957677King's College Hospital (UK)80
进行中(未招募)
不适用
A Pilot Study to Determine the Safety and Efficacy of Induction-Therapy, De Novo MPA and Delayed mTOR-Inhibition in Liver Transplant Recipients with Impaired Renal Function - PATRON-Study - CNI-free Prevention of Rejection in Liver Transplant Patients with Impaired Renal FunctioEvaluation of the safety and efficacy of CNI-free immunosuppressive treatment of patients undergoing liver transplantation with a preexisting renal impairment.MedDRA version: 9.1Level: LLTClassification code 10062237Term: Renal impairmentMedDRA version: 9.1Level: LLTClassification code 10024716Term: Liver transplantationMedDRA version: 9.1Level: LLTClassification code 10062016Term: Immunosuppression
EUCTR2007-003561-40-DERegensburg University Medical Center, Department of Surgery29